Cargando…

Allogeneic hematopoietic cell transplantation in patients ⩾70 years: which patients may benefit?

Detalles Bibliográficos
Autores principales:	Haen, S P, Pham, M, Faul, C, Dörfel, D, Vogel, W, Kanz, L, Bethge, W A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030379/ https://www.ncbi.nlm.nih.gov/pubmed/27391575 http://dx.doi.org/10.1038/bcj.2016.54

Ejemplares similares

P1268: ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR HIGH-RISK MYELODYSPLASTIC NEOPLASMS: A RETROSPECTIVE, SINGLE-CENTER ANALYSIS
por: Christian Schröder, Jan, et al.
Publicado: (2023)

Allogeneic hematopoietic cell transplantation outcomes in patients with Richter’s transformation
por: Kim, Haesook T., et al.
Publicado: (2021)

Toxoplasma Encephalitis in an Allogeneic Hematopoietic Stem Cell Transplant Recipient in Korea
por: Park, Soo-Kyung, et al.
Publicado: (2012)

Allogeneic hematopoietic stem cell transplantation for acute leukemia with Gilbert's syndrome
por: Yu, Guo-Pan, et al.
Publicado: (2011)

Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience
por: Chihara, Dai, et al.
Publicado: (2022)

Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogenic Hematopoietic Cell Transplantation
por: Henmi, Heisuke, et al.
Publicado: (2022)

Immune reconstitution profile after allogeneic hematopoietic stem cell transplantation with post-transplant cyclophosphamide
por: Espinoza-Gutarra, Manuel, et al.
Publicado: (2023)

Response to: Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogeneic Hematopoietic Cell Transplantation
por: Yanagiya, Ryo, et al.
Publicado: (2022)

Allogeneic hematopoietic cell transplantation in an adult patient with Glanzmann thrombasthenia
por: Cid, Ana R., et al.
Publicado: (2017)

Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
por: Chang, Ellen K., et al.
Publicado: (2021)

Successful treatment of myelodysplastic syndrome and Behcet colitis after allogeneic hematopoietic stem cell transplantation
por: Kook, Min-Ha, et al.
Publicado: (2014)

An isolated cardiac relapse after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia
por: Chang, Kiju, et al.
Publicado: (2017)

Progressive Hepatic Cirrhosis Early After Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Chronic Hepatitis C Infection
por: Kaito, Satoshi, et al.
Publicado: (2019)

Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
por: Robin, Marie, et al.
Publicado: (2019)

BK virus encephalitis without concurrent hemorrhagic cystitis in an allogeneic hematopoietic stem cell transplant recipient
por: Lee, Suk-young, et al.
Publicado: (2013)

Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag
por: Tang, Cen, et al.
Publicado: (2018)

T-cell immune response controls the high incidence of adenovirus infection in adult allogenic hematopoietic transplantation recipients
por: Sánchez-Céspedes, Javier, et al.
Publicado: (2020)

The safety and short‐term outcomes of allogeneic hematopoietic stem cell transplantation with donor vaccination for COVID‐19
por: Ding, Yihan, et al.
Publicado: (2022)

Acute liver failure associated with human adenovirus infection after allogeneic hematopoietic stem cell transplantation
por: Lin, Zhimin, et al.
Publicado: (2023)

Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation
por: Du, Wei, et al.
Publicado: (2018)

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)

Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
por: Kim, Hee-Je, et al.
Publicado: (2021)

Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation
por: Lutfi, Forat, et al.
Publicado: (2021)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE
por: Hale, Gregory A., et al.
Publicado: (2013)

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies
por: Zahid, Mohammad Faizan, et al.
Publicado: (2014)

Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms
por: Lim, Sung-Nam, et al.
Publicado: (2013)

Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Fanconi Anemia
por: Fumani, Hosein Kamranzadeh, et al.
Publicado: (2016)

Outcome of allogeneic hematopoietic cell transplantation in patients with adult T‐cell leukemia
por: Kamiunten, Ayako, et al.
Publicado: (2018)

Population pharmacokinetics of clofarabine for allogeneic hematopoietic cell transplantation in paediatric patients
por: Nijstad, A. Laura, et al.
Publicado: (2021)

Meta-analysis of the benefit of hypomethylating agents before allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes
por: Liu, Liu, et al.
Publicado: (2021)

Unusual isolated extramedullary relapse of acute lymphoblastic leukemia in the breast despite complete donor hematopoietic chimerism after allogeneic hematopoietic stem cell transplantation
por: Sung, Pack Hyun, et al.
Publicado: (2018)

Benefit of Reducing Body Weight Loss with A Nutritional Support Pathway in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
por: Aoyama, Takashi, et al.
Publicado: (2019)

A case of transplantation-associated thrombotic microangiopathy with autopsy-proven fatal myocardial ischemia after allogeneic hematopoietic stem cell transplantation
por: Sasaki, Ken, et al.
Publicado: (2020)

Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation
por: Einarsdottir, Sigrun, et al.
Publicado: (2022)

Creutzfeldt-Jakob Disease as a Reason for Neurological Deterioration in a Patient with Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
por: Karasek, Magdalena, et al.
Publicado: (2023)

Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: a single center experience.
por: Xue, Elisabetta, et al.
Publicado: (2023)

Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Concurrent Lymphoid Malignancy
por: Zimmerman, Zachary, et al.
Publicado: (2011)

Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
por: Alessandrino, Emilio Paolo, et al.
Publicado: (2013)

Allogeneic hematopoietic stem cell transplantation in patients with advanced indolent lymphoproliferative disorders
por: Fonseca-Hial, Ana Marcela Rojas, et al.
Publicado: (2016)

Physiological problems in patients undergoing autologous and allogeneic hematopoietic stem cell transplantation
por: Kapucu, Sevgisun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d0a0s7u4meggff35ofs6cqbfbk